EN
Home/Technology/Platforms

Platforms

Platforms

Consent Mode
3DμS®-CT 3DμS®-SE 3DμS®-MR 3DμS®-GR 3DμS®-OP

3D Microstructure for Modified Release

Structure Design of 3DμS®-MR
3DμS®-MR comprises a delay layer and a drug-containing core. Featuring innovative structures, 3DμS®-MR platform enables various release profile, including delayed release, immediate release, extended release, pulsed release, etc.
Application Scenarios of 3DμS®-MR
3DμS®-MR V1.0 meets the clinical needs for most of the drugs.

3DμS®-MR V2.0 further expands application scenarios, meets challenging drug delivery needs, facilitates drug product design and development.

3DμS®-MR V3.0 will be further developed to address more critical clinical needs, making it suitable for more diverse application scenarios.

Advantages of 3DμS®-MR

Accelerate R&D Process

Incorporating an X-ray imaging agent enables more accurate tracking of drug delivery and release in the Gl tract.

The accumulated experience in material science study and structural design enables the creation of various in vivo drug release behaviors, thereby providing an efficient development platform for complexformulations.

Improve Drug Efficacy

Well controlled programmed release enables accurate drug release at the desired time and Gl location with a desired rate. 3DμS®-MR platform is particularly suited to meeting unmet clinical needs for the drugs requiring sustained release, pulsatile release or those with a narrow therapeutic window.

Improve the drugability of challenging molecules.

Increase Productivity

The convenient MED® 3D printing continuous manufacturing process offers lower costs and ensures more consistent quality for complex formulations.

Business Development

Contact Us

苏ICP备17053162号 苏公网安备 32011502011777号

All Rights Reserved

Copyright © 2025 (TRIASTEK)

Contact Us

BD@triastek.com

Follow us on

Global

COPYRIGHT © 2025 TRIASTEK. 苏ICP备17053162号

DIGITAL By VTHINK